Target intelligence / Profile preview

Quinolone resistance protein NorA (NorA)

Target
NorA
Molecular classification
Transporter, Major facilitator superfamily (MFS), Multidrug efflux pump
01

Overview

Quinolone resistance protein NorA is a proton-coupled multidrug efflux transporter found in *Staphylococcus aureus* and belongs to the major facilitator superfamily (MFS)[5][7][8]. NorA actively exports a wide range of antibiotics and toxic compounds out of bacterial cells using a proton gradient, most notably conferring resistance to fluoroquinolones such as norfloxacin and ciprofloxacin[1][4][8]. Overexpression of NorA in S. aureus leads to multidrug resistance phenotypes, and its action is a key barrier to the successful treatment of MRSA infections[3][8]. NorA has become a target for developing efflux pump inhibitors, which could synergize with existing antibiotics to combat resistance[5][8]. The NorA family is defined by structural motifs conserved among MFS transporters, including essential acidic residues (Glu222 and Asp307) that mediate proton coupling and substrate recognition[8].

Other names
NorA efflux pumpNorA multidrug transporterStaphylococcus aureus NorAMultidrug resistance protein NorAMFS NorA
02

Mechanism of action

Drug/H+ antiporter: NorA pumps out antimicrobials and other substrates in exchange for protons, lowering the intracellular concentration of drugs and conferring resistance[1][6][8].

03

Biological functions

Drug effluxAntibiotic resistanceTransport of small molecules across the bacterial membrane
04

Disease associations

Infection (specifically, resistance in Staphylococcus aureus, including MRSA)
05

Safety considerations

Targeting NorA can potentially restore antibiotic sensitivity, but as it is a bacterial target, safety concerns are more related to possible off-target effects on human transporter homologs or microbiome disturbance[6][8].
06

Interacting drugs

Norfloxacin

9 more in the full profile.

07

Biomarkers

NorA gene or mRNA overexpression (as marker of multidrug resistance in S. aureus)

Beyond the preview

Go deeper on Quinolone resistance protein NorA (NorA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quinolone resistance protein NorA (NorA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call